Corrigendum to "ChanLingGao alleviates intestinal mucosal barrier damage and suppresses the onset and progression of Colorectal cancer in AOM/DSS murine model" [Int. Immunopharmacol. 143 (2024) 113193]
- PMID: 40473514
- DOI: 10.1016/j.intimp.2025.114932
Corrigendum to "ChanLingGao alleviates intestinal mucosal barrier damage and suppresses the onset and progression of Colorectal cancer in AOM/DSS murine model" [Int. Immunopharmacol. 143 (2024) 113193]
Erratum for
-
ChanLingGao alleviates intestinal mucosal barrier damage and suppresses the onset and progression of Colorectal cancer in AOM/DSS murine model.Int Immunopharmacol. 2024 Dec 25;143(Pt 1):113193. doi: 10.1016/j.intimp.2024.113193. Epub 2024 Oct 4. Int Immunopharmacol. 2024. PMID: 39368132
Publication types
LinkOut - more resources
Full Text Sources